Lumito’s Scientific Advisory Board Meeting Held and Additional Key Opinion Leader Joins
Following the establishment of its Scientific Advisory Board (SAB) announced on 5 June 2025, the SAB held a meeting this week, where the uniqueness of Lumito’s solution, Scizys, was confirmed and reaffirmed as a promising technology with the potential to lead the way in quantitative tissue analysis and pathology. Lumito are pleased to announce that […]
Lumito establishes Scientific Advisory Board with leading international experts in drug development, pathology, and oncology
Lumito has established a Scientific Advisory Board (SAB) to primarily support its ongoing commercialisation and, in the longer term, to strengthen the company’s strategic efforts toward a product for clinical use. The board comprises globally recognised experts in pathology, diagnostics, oncology, digitalisation, and drug development, with extensive experience spanning academia, healthcare, and the pharmaceutical industry. […]
